GG 339 175
Pill imprint GG 339 175 has been identified as Levothyroxine sodium 175 mcg.
Levothyroxine is used in the treatment of underactive thyroid; hypothyroidism, after thyroid removal; hashimoto's disease; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy.
Levothyroxine 175 mcg is not subject to the Controlled Substances Act.
See also related documents.
Levothyroxine sodium Images
- Imprint:
-
GG 339
175 - Strength:
- 175 mcg
- Color:
- Purple
- Size:
- 9.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
silicon dioxide colloidal
sodium starch glycolate
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-5188
| NDC Code | Manufacturer / Repackager |
|---|---|
| 21695-0757 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Levothyroxine Sodium resources
- Levothyroxine
- Levothyroxine (Wolters Kluwer)
- Levothyroxine Capsules (Wolters Kluwer)
- Levothyroxine Solution (Wolters Kluwer)
- levothyroxine (Cerner Multum)
- levothyroxine (Micromedex) - Includes Dosage Information
- levothyroxine Injection (Micromedex) - Includes Dosage Information
- Levothyroxine Sodium (AHFS DI)
- Levothyroxine (FDA)
- Novothyrox (FDA)
- Levothyroxine Sodium (T4; L-thyroxine) (Wolters Kluwer)
Search Again
